Hematopoietic and Lymphoid Cell Neoplasm

Oncology
1
Pipeline Programs
3
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket

Drug Modality Breakdown

Small Molecule
1100%
+ 1 programs with unclassified modality

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Knight Therapeutics
Knight TherapeuticsQC - Montréal
1 program
1
Lopinavir/RitonavirPhase 2Small Molecule1 trial
Active Trials
NCT04455958Withdrawn0Est. Nov 2021
City Therapeutics
City TherapeuticsMA - Cambridge
1 program
Internet-Based InterventionN/A1 trial
Active Trials
NCT05173961Active Not RecruitingEst. Jun 2026

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Knight TherapeuticsLopinavir/Ritonavir
City TherapeuticsInternet-Based Intervention

Clinical Trials (2)

Lopinavir/Ritonavir for the Treatment of COVID-19 Positive Patients With Cancer and Immune Suppression in the Last Year

Start: May 2021Est. completion: Nov 20210
Phase 2Withdrawn
NCT05173961City TherapeuticsInternet-Based Intervention

A Mobile Application, Oncpatient, to Assist Patients Undergoing Radiation Therapy

Start: Jun 2022Est. completion: Jun 2026
N/AActive Not Recruiting

Related Jobs in Oncology

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

3 companies competing in this space